
Sign up to save your podcasts
Or


Shares in Juno Therapeutics and Amicus Therapeutics tumble on disappointing news; and one important drug at Pfizer takes a big step forward.
By The Motley FoolShares in Juno Therapeutics and Amicus Therapeutics tumble on disappointing news; and one important drug at Pfizer takes a big step forward.